Skip to content

SaberX Radianz R51003004LRecalls & reported problems

Cordis US Corp. · SABERX RADIANZ 3MM4CM 190 · Class 2

All models of SaberX Radianz (24)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 20705032081815), received between Mar 11, 2024 and Mar 2, 2026 — classified as 5 malfunctions.

The most frequently reported specific device problem is “Burst Container or Vessel” (5 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Burst Container or Vessel5

Patient problems

  • No Clinical Signs, Symptoms or Conditions5

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 2, 2026Burst Container or Vessel

    AS REPORTED, THE 3MM 4CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON RUPTURED DURING INFLATION. THE PROCEDURE WAS COMPLETED USING A NEW 4MM 4CM SABERX RADIANZ DEVICE. THERE WAS NO REPORTED INJURY TO THE PATIENT. THE PRODUCT WAS STORED PROPERLY ACCORDING TO THE INSTRUCTIONS FOR USE (IFU). NO DIFFICULTY WAS ENCOUNTERED WHEN REMOVING IT FROM THE HOOP, PROTECTIVE BALLOON COVER, STYLET, OR ANY STERILE PACKAGING COMPONENTS. NO KINKS OR DAMAGES WERE NOTED PRIOR TO USE. THE DEVICE WAS PREPPED ACCORDING TO THE IFU AND MAINTAINED NEGATIVE PRESSURE. THE INTENDED PROCEDURE WAS TRI (TRANSRADIAL INTERVENTION) TARGETING THE ILIAC ARTERY. THE LESION WAS SEVERELY CALCIFIED WITH MODERATE VESSEL TORTUOSITY AND 90% STENOSIS. THE DEVICE WAS NOT USED FOR A CHRONIC TOTAL OCCLUSION (CTO). NO RESISTANCE OR FRICTION WAS EXPERIENCED WHEN INSERTING THE BALLOON THROUGH THE ROTATING HEMOSTATIC VALVE OR THE GUIDE CATHETER. THERE WAS NO DIFFICULTY ADVANCING THE BALLOON CATHETER THROUGH THE VESSEL OR CROSSING THE LESION. THE CATHETER WAS NOT PLACED IN AN ACUTE BEND, AND NO KINKING OCCURRED DURING USE. A 50:50 CONTRAST-TO-SALINE RATIO WAS USED. THE DEVICE WAS DISCARDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24483810 ↗
  • MalfunctionMar 11, 2025Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, AFTER DELIVERING A 3MM X 4CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER TO THE LESION, THE BALLOON RUPTURED DURING ITS INITIAL INFLATION TO 8 ATMOSPHERES (ATM). A NEW SABERX PTA BALLOON CATHETER WAS USED AS A REPLACEMENT TO COMPLETE THE PROCEDURE. THERE WERE NO REPORTED INJURIES TO THE PATIENT. THE TARGET VESSEL WAS THE SUPERFICIAL FEMORAL ARTERY (SFA), WITH MILD CALCIFICATION, MILD TORTUOSITY, AND 90% STENOSIS. THE DEVICE WAS STORED AND PREPPED PER THE INSTRUCTIONS FOR USE (IFU). THERE WAS NO DIFFICULTY REMOVING ANY OF THE STERILE PACKAGING COMPONENTS. THE DEVICE MAINTAINED NEGATIVE PRESSURE DURING PREPARATION. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21574742 ↗
  • MalfunctionFeb 25, 2025Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, THE BALLOON OF A 3MM X 4CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER RUPTURED DURING ITS INITIAL INFLATION TO 8 ATMOSPHERES (ATM). THERE WERE NO REPORTED INJURIES TO THE PATIENT. THE TARGET VESSEL WAS THE ILIAC. THE TARGET SITE VESSEL CHARACTERISTICS WERE MODERATE CALCIFICATION, MILD TORTUOSITY, AND 90% STENOSIS. THE DEVICE WAS STORED AND PREPPED PER THE INSTRUCTIONS FOR USE (IFU) AND THERE WAS NO DIFFICULTY REMOVING ANY OF THE STERILE PACKAGING COMPONENTS. THE DEVICE MAINTAINED NEGATIVE PRESSURE DURING PREPARATION. THE DEVICE WAS ABLE TO BE DELIVERED TO THE LESION. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21458095 ↗
  • MalfunctionApr 30, 2024Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, THE BALLOON OF A 3MM X 4CM SABERX RADIANZ PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER RUPTURED AT 8 ATMOSPHERES (ATM) DURING ITS INITIAL INFLATION. A NEW UNKNOWN SABER PTA BALLOON CATHETER WAS USED AS A REPLACEMENT. THERE WERE NO REPORTED INJURIES TO THE PATIENT. THIS WAS DURING A PROCEDURE TO TREAT A 90% STENOSED SUPERFICIAL FEMORAL ARTERY (SFA) LESION WHICH HAD MODERATE CALCIFICATION AND MILD TORTUOSITY. THE DEVICE WAS STORED AND PREPPED PER THE INSTRUCTIONS FOR USE (IFU) AND THERE WERE NO DIFFICULTIES REMOVING ANY OF THE STERILE PACKAGING COMPONENTS. THE DEVICE WAS ABLE TO MAINTAIN NEGATIVE PRESSURE DURING PREPARATION. THE DEVICE WAS ABLE TO BE REMOVED EASILY FROM THE PATIENT AND REMAINED IN ONE PIECE DURING ITS REMOVAL. THE DEVICE WILL NOT BE RETURNED FOR EVALUATION.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19212169 ↗
  • MalfunctionMar 11, 2024Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, THE 3MM 4CM SABER PTA (RADIANZ) WAS USED FOR PRE-DILATION. HOWEVER, THE PRESSURE WAS UNABLE TO RISE OVER ITS NOMINAL PRESSURE. THE PHYSICIAN SUSPECTED THE COMPLAINT DEVICE RUPTURED. THEREFORE, THE COMPLAINT DEVICE WAS REMOVED, AND OTHER BALLOON CATHETER(S) (NON-CORDIS) WERE USED TO CONTINUE THE PROCEDURE. THE DEVICE WAS REMOVED INTACT FROM THE PATIENT. AFTER THAT, THE PHYSICIAN CONFIRMED THAT FOUR OF BALLOON CATHETERS (NON-CORDIS) RUPTURED BUT THE LESION WAS GRADUALLY INFLATED, AND STENT(S) WERE IMPLANTED, AND THE PROCEDURE COMPLETED. THIS ISSUE MIGHT HAVE CAUSED BY SEVERE CALCIFICATION. THERE WAS NO REPORTED INJURY TO THE PATIENT. THE LESION WAS THE ILIAC ARTERY. AN UNKNOWN GUIDEWIRE CROSSED THE LESION. THE PRODUCT WAS STORED PROPERLY ACCORDING TO THE INSTRUCTIONS FOR USE. THERE IS NO DIFFICULTY REMOVING THE PRODUCT FROM THE HOOP, REMOVING THE PROTECTIVE BALLOON COVER, STYLET, OR ANY OF THE STERILE PACKAGING COMPONENTS. THERE WERE NO KINKS OR OTHER DAMAGES NOTED PRIOR TO INSERTING THE DEVICE INTO THE PATIENT. THE DEVICE WAS PREPPED PER THE IFU. THE DEVICE WAS PREPPED NORMALLY AND WAS ABLE TO MAINTAIN NEGATIVE PRESSURE. THE VESSEL WAS NOTED IT DID NOT HAVE ANY TORTUOSI

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18876493 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page